SEARCH

SEARCH BY CITATION

References

  • 1
    Sasieni P, Adams J, Cuzick J. Benefit of cervical screening at different ages: evidence from the UK audit of screening histories. Br J Cancer 2003;89:8893.
  • 2
    Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999;318:9048.
  • 3
    Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004;364:24956.
  • 4
    Kitchener HC, Castle PE, Cox JT. Chapter 7: achievements and limitations of cervical cytology screening. Vaccine 2006;24(Suppl. 3):S6370.
  • 5
    Schiffman M, Castle PE. The promise of global cervical-cancer prevention. N Engl J Med 2005;353:21014.
  • 6
    NHS Cervical Screening Programme. Colposcopy and Programme Management: Guidelines for the NHS Cervical Screening Programme. Sheffield: NHSCSP Publication No 20; 2004.
  • 7
    Wright TC, Cox TJ, Massad S et al. 2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. Am J Obstet Gynecol 2004;189:295304.
  • 8
    Jordan J, Arbyn M, Martin-Hirsch P et al. European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology, part 1. Cytopathology 2008;19:34254.
  • 9
    Jordan J, Martin-Hirsch P, Arbyn M et al. European guidelines for clinical management of abnormal cervical cytology, Part 2. Cytopathology 2009;20:516.
  • 10
    Prendiville W, Walker P, Jordan J, Shafi MI. Standards for Service Provision in Colposcopy Services. London: Royal College of Obstetricians and Gynaecologists; 2006.
  • 11
    Luesley DM, McCrum A, Tery PB et al. Complications of cone biopsy related to the dimensions of the cone and the influence of prior colposcopic assessment. Br J Obstet Gynaecol 1985;92:15864.
  • 12
    Sommaruga P, Schwatr D, Pelte MF et al. Predictive value of loop electrosurgical excision procedure (LEEP) margin for cervical intraepithelial neoplasia (CIN) recurrence. Int J Gynecol Cancer 2005;15(Suppl. 2):589.
  • 13
    Prendiville W, De Camargo M, Walker P. The use and abuse of LLETZ. CME J Gynaecol Oncol 2000;5:857.
  • 14
    Walker P, Dexeus S, De Paol G et al. International Federation for Cervical Pathology and Colposcopy Nomenclature Committee. Obstet Gynecol 2003;101:1757.
  • 15
    Anderson M, Hartley T. Cervical crypt involvement by intra-epithelial neoplasia. Obstet Gynecol 1980;55:54650.
  • 16
    Duncan IA. The Semm cold coagulator in the management of CIN. Clin Obstet Gynecol 1983;26:9961006.
  • 17
    Duncan IA. Cold coagulation. Bailliere’s Clin Obstet Gynaecol 1995;9:14555.
  • 18
    Gordon HK, Duncan ID. Effective destruction of cervical intraepithelial neoplasia (CIN) at 100 C using the Semm cold coagulator. 14 years experience. Br J Obstet Gynaecol 1991;98:1421.
  • 19
    Crisp WE, Asadourian L, Romberger W. Application of cryosurgery to gynecologic malignancy. Obstet Gynecol 1967;30:66873.
  • 20
    Creasman WT, Weed JC Jr, Curry SL, Johnston WW, Parker RT. Efficacy of cryosurgical treatment of severe cervical intraepithelial neoplasia. Obstet Gynaecol 1973;41:5016.
  • 21
    Jordan JA, Woodman CB, Mylotte MJ et al. The treatment of cervical intraepithelial neoplasia by laser vaporization. Br J Obstet Gynaecol 1985;92:3948.
  • 22
    Monaghan JM. Laser vaporization and excisional techniques in the treament of cervical intraepithelial neoplasia. Bailliere’s Clin Obstet Gynaecol 1995;9:17387.
  • 23
    Chanen W. Electrocoagulation diathermy. Baillieres Clin Obstet Gynecol 1995;9:15772.
  • 24
    Arbyn M, Kyrgiou M, Simoens C et al. Perinatal mortality and other severe adverse pregnancy outcomes associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ 2008;337:a1284. doi: DOI: 10.1136/bmj.a1284 (Published 18 September 2008).
  • 25
    Prendiville W, Cullimore J, Norman S. Large loop excision of the transformation zone (LLETZ). A new method of management for women with cervical intra-epithelial neoplasia. Br J Obstet Gynaecol 1989;96:105460.
  • 26
    Prendiville W. LLETZ: theoretical rationale, practical aspects, clinical experience, optimizing the technique. In: Colposcopy: Management Options. PrendivilleW, RitterJ, TattiS, TwiggsL (eds). Philadelphia WB: Saunders; 2003: Ch10.
  • 27
    Prendiville W. Excision of the transformation zone. In: Lower Genital Tract Neoplasia. MacleanA, SingerA, CritchleyH (eds). London: RCOG Press; 2003: pp. 17988.
  • 28
    Prendiville W. The treatment of grade 3 cervical intraepithelial neoplasia. In: Colposcopy: Management Options. PrendivilleW, RitterJ, TattiS, TwiggsL (eds). Philadelphia WB: Saunders; 2003: Ch15.
  • 29
    Martin-Hirsch PL, Paraskevaidis E, Kitchener H. Surgery for cervical intraepithelial neoplasia. Cochrane Database Syst Rev 2002;3:CD001318.
  • 30
    Shafi MI, Jordan JA, Singer A. The management of cervical intraepithelial neoplasia. In: The Cervix. JordanJA, SingerA, JonesH, ShafiMI (eds). Oxford: Blackwell publications; 2006: p. 465.
  • 31
    Dobbs P, Asmussen TM, Nuns D et al. Does histological incomplete excision of CIN following LLETZ increase recurrence rates? A six-year cytological follow-up. Br J Obstet Gynaecol 2000;107:1298301.
  • 32
    Flannelly G, Langham H, Jandial L et al. A study of treatment failures following large loop excision of the transformation zone for the treatment of cervical intraepithelial neoplasia. Br J Obstet Gynaecol 1997;104:71832.
  • 33
    Flannelly G, Bolger B, Fawzi HD et al. Follow-up after LLETZ: could schedules be modified according to risk of recurrence. Br J Obstet Gynaecol 2001;108:102530.
  • 34
    Gardeil F, Barry-Walsh C, Prendiville W, Clinch J, Turner MJ. Persistent intraepithelial neoplasia after excision for cervical intraepithelial neoplasia grade III. Obstet Gynecol 1997;89:41922.
  • 35
    Ghaem-Maghami S, Sagi S, Majeed G, Soutter WP. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis. Lancet Oncol 2007;8:98593.
  • 36
    Dimitriou E, Khalid S, Prendiville W. The Relation of Type Of Excision and Clear Histopathological Margins After LLETZ. Dublin: BSCCP presentation; 2009.
  • 37
    Wright VC. Color Atlas of Colposcopy: Cervix, Vagina and Vulva. Houston: Biomedical Communications; 2000.
  • 38
    Cullimore JE, Luesley DM, Rollason TP et al. A prospective study of conization of the cervix in the management of cervical intraepithelial glandular neoplasia (CIGN) – a preliminary report. Br J Obstet Gynaecol 1992;99:3148.
  • 39
    Lopes A, Baynon G, Robertson G, Varas V, Monaghan JM. Short term morbidity following large loop excision of the cervical transformation zone. J Obstet Gynaecol 1994;14:1979.
  • 40
    Larson G. Conisation for pre-invasive and invasive carcinoma. Acta Obstet Gynecol Scand 1983; Supplementary Issue 114:140.
  • 41
    Kyrgiou M, Koliopoulos G, Martin-Hirsch P et al. Obstetric outcomes after conservative treatment for intra-epithelial or early invasive cervical lesions: a systematic review and meta-analysis of the literature. Lancet 2006;367:48998.
  • 42
    Khalid S, Dimitriou E, Prendiville W. Risk of Premature Labour After LLETZ: Does Size Matter. Dublin: Presentation BSCCP Scientific Meeting; 2009.
  • 43
    Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005;99(3 Suppl. 1):S711.
  • 44
    Kitchener HC, Walker PG, Nelson L et al. HPV testing as an adjunct to cytology in the follow up of women treated for cervical intraepithelial neoplasia. Br J Obstet Gynaecol 2008;115:10017.
  • 45
    Soutter WP, Sasieni P, Panoskaltsis T. Long-term risk of invasive cercical cancer after treatment of squamous cervical intraepithelial neoplasia. Int J Cancer 2006;118:204855.
  • 46
    Kalliala I, Anttla A, Pukkala E, Nieminen P. Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study. BMJ (Primary Care) 2005;381:11835.
  • 47
    Strander B, Andersson-Ellström A, Milsom I, Sparén P. Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study. BMJ 2007;335:1077.